The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Cold Treatment Drug Market Research Report 2025

Global Cold Treatment Drug Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1721240

No of Pages : 102

Ask Your Query
Synopsis
This report focus on OTC drugs and wellness drugs to treat cold symptoms and respiratory infections.
The global Cold Treatment Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Cold Treatment Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cold Treatment Drug.
Report Scope
The Cold Treatment Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cold Treatment Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cold Treatment Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Johnson & Johnson
VICKS
TEVA
Bayer
GSK
Novartis
Centrient Pharma
Mylan
Cipla
NCPC
United Laboratories
Sun Pharma
CSPC
LKPC
Hikma
Dr. Reddy
HPGC
Aurubindo
Meiji Holdings
Sudafed
Merck
Reckitt Benckiser
TYLENOL
Segment by Type
Cough Medicine
Respiratory Infections
Others
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cold Treatment Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cold Treatment Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Cough Medicine
1.2.3 Respiratory Infections
1.2.4 Others
1.3 Market by Application
1.3.1 Global Cold Treatment Drug Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cold Treatment Drug Market Perspective (2019-2030)
2.2 Cold Treatment Drug Growth Trends by Region
2.2.1 Global Cold Treatment Drug Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cold Treatment Drug Historic Market Size by Region (2019-2024)
2.2.3 Cold Treatment Drug Forecasted Market Size by Region (2025-2030)
2.3 Cold Treatment Drug Market Dynamics
2.3.1 Cold Treatment Drug Industry Trends
2.3.2 Cold Treatment Drug Market Drivers
2.3.3 Cold Treatment Drug Market Challenges
2.3.4 Cold Treatment Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cold Treatment Drug Players by Revenue
3.1.1 Global Top Cold Treatment Drug Players by Revenue (2019-2024)
3.1.2 Global Cold Treatment Drug Revenue Market Share by Players (2019-2024)
3.2 Global Cold Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cold Treatment Drug Revenue
3.4 Global Cold Treatment Drug Market Concentration Ratio
3.4.1 Global Cold Treatment Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cold Treatment Drug Revenue in 2023
3.5 Cold Treatment Drug Key Players Head office and Area Served
3.6 Key Players Cold Treatment Drug Product Solution and Service
3.7 Date of Enter into Cold Treatment Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cold Treatment Drug Breakdown Data by Type
4.1 Global Cold Treatment Drug Historic Market Size by Type (2019-2024)
4.2 Global Cold Treatment Drug Forecasted Market Size by Type (2025-2030)
5 Cold Treatment Drug Breakdown Data by Application
5.1 Global Cold Treatment Drug Historic Market Size by Application (2019-2024)
5.2 Global Cold Treatment Drug Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cold Treatment Drug Market Size (2019-2030)
6.2 North America Cold Treatment Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cold Treatment Drug Market Size by Country (2019-2024)
6.4 North America Cold Treatment Drug Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cold Treatment Drug Market Size (2019-2030)
7.2 Europe Cold Treatment Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cold Treatment Drug Market Size by Country (2019-2024)
7.4 Europe Cold Treatment Drug Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cold Treatment Drug Market Size (2019-2030)
8.2 Asia-Pacific Cold Treatment Drug Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cold Treatment Drug Market Size by Region (2019-2024)
8.4 Asia-Pacific Cold Treatment Drug Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cold Treatment Drug Market Size (2019-2030)
9.2 Latin America Cold Treatment Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cold Treatment Drug Market Size by Country (2019-2024)
9.4 Latin America Cold Treatment Drug Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cold Treatment Drug Market Size (2019-2030)
10.2 Middle East & Africa Cold Treatment Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cold Treatment Drug Market Size by Country (2019-2024)
10.4 Middle East & Africa Cold Treatment Drug Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Cold Treatment Drug Introduction
11.1.4 Pfizer Revenue in Cold Treatment Drug Business (2019-2024)
11.1.5 Pfizer Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Detail
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Cold Treatment Drug Introduction
11.2.4 Johnson & Johnson Revenue in Cold Treatment Drug Business (2019-2024)
11.2.5 Johnson & Johnson Recent Development
11.3 VICKS
11.3.1 VICKS Company Detail
11.3.2 VICKS Business Overview
11.3.3 VICKS Cold Treatment Drug Introduction
11.3.4 VICKS Revenue in Cold Treatment Drug Business (2019-2024)
11.3.5 VICKS Recent Development
11.4 TEVA
11.4.1 TEVA Company Detail
11.4.2 TEVA Business Overview
11.4.3 TEVA Cold Treatment Drug Introduction
11.4.4 TEVA Revenue in Cold Treatment Drug Business (2019-2024)
11.4.5 TEVA Recent Development
11.5 Bayer
11.5.1 Bayer Company Detail
11.5.2 Bayer Business Overview
11.5.3 Bayer Cold Treatment Drug Introduction
11.5.4 Bayer Revenue in Cold Treatment Drug Business (2019-2024)
11.5.5 Bayer Recent Development
11.6 GSK
11.6.1 GSK Company Detail
11.6.2 GSK Business Overview
11.6.3 GSK Cold Treatment Drug Introduction
11.6.4 GSK Revenue in Cold Treatment Drug Business (2019-2024)
11.6.5 GSK Recent Development
11.7 Novartis
11.7.1 Novartis Company Detail
11.7.2 Novartis Business Overview
11.7.3 Novartis Cold Treatment Drug Introduction
11.7.4 Novartis Revenue in Cold Treatment Drug Business (2019-2024)
11.7.5 Novartis Recent Development
11.8 Centrient Pharma
11.8.1 Centrient Pharma Company Detail
11.8.2 Centrient Pharma Business Overview
11.8.3 Centrient Pharma Cold Treatment Drug Introduction
11.8.4 Centrient Pharma Revenue in Cold Treatment Drug Business (2019-2024)
11.8.5 Centrient Pharma Recent Development
11.9 Mylan
11.9.1 Mylan Company Detail
11.9.2 Mylan Business Overview
11.9.3 Mylan Cold Treatment Drug Introduction
11.9.4 Mylan Revenue in Cold Treatment Drug Business (2019-2024)
11.9.5 Mylan Recent Development
11.10 Cipla
11.10.1 Cipla Company Detail
11.10.2 Cipla Business Overview
11.10.3 Cipla Cold Treatment Drug Introduction
11.10.4 Cipla Revenue in Cold Treatment Drug Business (2019-2024)
11.10.5 Cipla Recent Development
11.11 NCPC
11.11.1 NCPC Company Detail
11.11.2 NCPC Business Overview
11.11.3 NCPC Cold Treatment Drug Introduction
11.11.4 NCPC Revenue in Cold Treatment Drug Business (2019-2024)
11.11.5 NCPC Recent Development
11.12 United Laboratories
11.12.1 United Laboratories Company Detail
11.12.2 United Laboratories Business Overview
11.12.3 United Laboratories Cold Treatment Drug Introduction
11.12.4 United Laboratories Revenue in Cold Treatment Drug Business (2019-2024)
11.12.5 United Laboratories Recent Development
11.13 Sun Pharma
11.13.1 Sun Pharma Company Detail
11.13.2 Sun Pharma Business Overview
11.13.3 Sun Pharma Cold Treatment Drug Introduction
11.13.4 Sun Pharma Revenue in Cold Treatment Drug Business (2019-2024)
11.13.5 Sun Pharma Recent Development
11.14 CSPC
11.14.1 CSPC Company Detail
11.14.2 CSPC Business Overview
11.14.3 CSPC Cold Treatment Drug Introduction
11.14.4 CSPC Revenue in Cold Treatment Drug Business (2019-2024)
11.14.5 CSPC Recent Development
11.15 LKPC
11.15.1 LKPC Company Detail
11.15.2 LKPC Business Overview
11.15.3 LKPC Cold Treatment Drug Introduction
11.15.4 LKPC Revenue in Cold Treatment Drug Business (2019-2024)
11.15.5 LKPC Recent Development
11.16 Hikma
11.16.1 Hikma Company Detail
11.16.2 Hikma Business Overview
11.16.3 Hikma Cold Treatment Drug Introduction
11.16.4 Hikma Revenue in Cold Treatment Drug Business (2019-2024)
11.16.5 Hikma Recent Development
11.17 Dr. Reddy
11.17.1 Dr. Reddy Company Detail
11.17.2 Dr. Reddy Business Overview
11.17.3 Dr. Reddy Cold Treatment Drug Introduction
11.17.4 Dr. Reddy Revenue in Cold Treatment Drug Business (2019-2024)
11.17.5 Dr. Reddy Recent Development
11.18 HPGC
11.18.1 HPGC Company Detail
11.18.2 HPGC Business Overview
11.18.3 HPGC Cold Treatment Drug Introduction
11.18.4 HPGC Revenue in Cold Treatment Drug Business (2019-2024)
11.18.5 HPGC Recent Development
11.19 Aurubindo
11.19.1 Aurubindo Company Detail
11.19.2 Aurubindo Business Overview
11.19.3 Aurubindo Cold Treatment Drug Introduction
11.19.4 Aurubindo Revenue in Cold Treatment Drug Business (2019-2024)
11.19.5 Aurubindo Recent Development
11.20 Meiji Holdings
11.20.1 Meiji Holdings Company Detail
11.20.2 Meiji Holdings Business Overview
11.20.3 Meiji Holdings Cold Treatment Drug Introduction
11.20.4 Meiji Holdings Revenue in Cold Treatment Drug Business (2019-2024)
11.20.5 Meiji Holdings Recent Development
11.21 Sudafed
11.21.1 Sudafed Company Detail
11.21.2 Sudafed Business Overview
11.21.3 Sudafed Cold Treatment Drug Introduction
11.21.4 Sudafed Revenue in Cold Treatment Drug Business (2019-2024)
11.21.5 Sudafed Recent Development
11.22 Merck
11.22.1 Merck Company Detail
11.22.2 Merck Business Overview
11.22.3 Merck Cold Treatment Drug Introduction
11.22.4 Merck Revenue in Cold Treatment Drug Business (2019-2024)
11.22.5 Merck Recent Development
11.23 Reckitt Benckiser
11.23.1 Reckitt Benckiser Company Detail
11.23.2 Reckitt Benckiser Business Overview
11.23.3 Reckitt Benckiser Cold Treatment Drug Introduction
11.23.4 Reckitt Benckiser Revenue in Cold Treatment Drug Business (2019-2024)
11.23.5 Reckitt Benckiser Recent Development
11.24 TYLENOL
11.24.1 TYLENOL Company Detail
11.24.2 TYLENOL Business Overview
11.24.3 TYLENOL Cold Treatment Drug Introduction
11.24.4 TYLENOL Revenue in Cold Treatment Drug Business (2019-2024)
11.24.5 TYLENOL Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock